[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1734221906151165952.png) @Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about ticker, avg, $osrh, $thtx the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1734221906151165952/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1734221906151165952/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +32%
- X Months XXXXXX -XX%
- X Year XXXXXXX +409%

### Mentions: XX [#](/creator/twitter::1734221906151165952/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1734221906151165952/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX +30%
- X Months XXX +937%
- X Year XXX +1,410%

### Followers: XXX [#](/creator/twitter::1734221906151165952/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1734221906151165952/c:line/m:followers.svg)

- X Week XXX +4.70%
- X Month XXX +11%
- X Months XXX +53%
- X Year XXX +85%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1734221906151165952/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1734221906151165952/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1734221906151165952/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [countries](/list/countries)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[ticker](/topic/ticker) 2.94%, [avg](/topic/avg) 1.96%, [$osrh](/topic/$osrh) 1.96%, [$thtx](/topic/$thtx) 1.96%, [$7846t](/topic/$7846t) 0.98%, [$adtx](/topic/$adtx) 0.98%, [$cgtx](/topic/$cgtx) 0.98%, [mayo](/topic/mayo) 0.98%, [$bctx](/topic/$bctx) 0.98%, [china](/topic/china) XXXX%

**Top assets mentioned**
[Bruker, Corp. (BRKR)](/topic/$brkr) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Magic Eden (ME)](/topic/$me) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Public Masterpiece Token (PMT)](/topic/$pmt) [Oobit (OBT)](/topic/$obt) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [GLOBUS MEDICAL INC (GMED)](/topic/$gmed)
### Top Social Posts [#](/creator/twitter::1734221906151165952/posts)
---
Top posts by engagements in the last XX hours

"$ADTX 1.31$ XXXX% July XX 2025 Aditxts Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic Ovarian Test"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948409119670710424) 2025-07-24 15:45:08 UTC XXX followers, XX engagements


"Top Market Movers: Positive News Full Access: $CGTX 0.75$ XXXX% July XX 2025 Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesines Protection of Neurons and Synapses in Alzheimers Disease"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947684317205041554) 2025-07-22 15:45:02 UTC XXX followers, XXX engagements


"$BCTX 0.83$ XXXX% July XX 2025 BriaCell Adds Mayo Clinic to Phase X Study in Metastatic Breast Cancer"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1945510006780276823) 2025-07-16 15:45:06 UTC XXX followers, XXX engagements


"Top Market Movers: Positive News Full Access: $BIAF 0.32$ XXXX% July XX 2025 bioAffinity Technologies Announces Notification of China Patent Award for Companys Noninvasive Lung Cancer Diagnostic"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1945509992901317045) 2025-07-16 15:45:02 UTC XXX followers, XXX engagements


"Latest catalysts: $ANVS Catalyst Date - 2025-07-27 Drug - buntanetap Treatment - Alzheimer's disease"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948771486229299686) 2025-07-25 15:45:03 UTC XXX followers, XXX engagements


"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ANEB - 689.0K - 20.1M - XXXXX $CLSD - 8.3M - 227.9M - XXXXX $RNAZ - 164.0K - 4.2M - 25.42"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948409098451714053) 2025-07-24 15:45:03 UTC XXX followers, XXX engagements


"$APYX 2.48$ XXXX% July XX 2025 Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August X 2025"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948771509583097903) 2025-07-25 15:45:08 UTC XXX followers, XX engagements


"Sionna Therapeutics (NASDAQ: $SION) is making waves in a tough biotech IPO market. The company just raised $219M in its IPO targeting cystic fibrosis (CF) with a novel undruggable approach. Their therapies could restore near-normal CFTR function for over XX% of CF patients addressing gaps left by current treatments. Key points: Positive Phase X data for lead candidates SION-719 and SION-451 with Phase 2a trials starting soon Global CF therapy market projected to reach $39B by 2034 Strong cash runway through 2028 all analysts rate Sionna a Buy Major milestone: mid-2026 clinical data readout"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948427594489364784) 2025-07-24 16:58:33 UTC XXX followers, XXX engagements


"$BRKR 35.80$ -XXXXX% July XX 2025 Bruker Announces Second Quarter 2025 Preliminary Results Plans to Hold Q2 Earnings Conference Call on August X 2025"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947321948998136218) 2025-07-21 15:45:06 UTC XXX followers, XX engagements


"Top Market Movers: Positive News Full Access: $OSRH 1.01$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948771481015779454) 2025-07-25 15:45:02 UTC XXX followers, XXX engagements


"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $XRTX - 148.1K - 3.5M - XXXXX $THTX - 477.5K - 10.6M - XXXXX $BCDA - 150.5K - 3.0M - 20.18"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1941161342976827642) 2025-07-04 15:45:03 UTC XXX followers, XX engagements


"$APLS Catalyst Date - 2025-07-28 Drug - EMPAVELI (pegcetacoplan) Treatment - C3 glomerulopathy primary immune complex membranoproliferative glomerulonephritis"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948771531662000501) 2025-07-25 15:45:14 UTC XXX followers, XXX engagements


"Top Market Movers: Positive News Full Access: $PSTV 0.62$ XXXXX% July XX 2025 Plus Therapeutics Announces $XXX Million Advance Payment from CPRIT"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948409093380829201) 2025-07-24 15:45:02 UTC XXX followers, XXX engagements


"Latest catalysts: $IMAB Catalyst Date - 2025-07-02 Drug - Givastomig (Claudin XXXX x 4-1BB bispecific antibody) Treatment - Claudin 18.2-positive metastatic gastric cancers"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1940074177643569655) 2025-07-01 15:45:03 UTC XXX followers, XXX engagements


"Top Market Movers: Negative News Full Access: $EVO 3.66$ -XXXXX% July XX 2025 Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947321934708080842) 2025-07-21 15:45:03 UTC XXX followers, XXX engagements


"$ALKS 26.50$ -XXXX% July XX 2025 Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947321959748075912) 2025-07-21 15:45:09 UTC XXX followers, XXX engagements


"$OSRH 1.08$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948409129137279260) 2025-07-24 15:45:10 UTC XXX followers, XXX engagements


"$ATYR 6.71$ XXXXX% July XX 2025 aTyr Pharma Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948046707532685633) 2025-07-23 15:45:02 UTC XXX followers, XXX engagements


"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $NCNA - 0.05$ - 128.8M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1943698059592118760) 2025-07-11 15:45:04 UTC XXX followers, XXX engagements


"$INMB Catalyst Date - 2025-07-27 Drug - XPro (selective soluble TNF inhibitor) Treatment - early Alzheimers Disease (AD) with biomarkers of inflammation"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947321968853934242) 2025-07-21 15:45:11 UTC XXX followers, XXX engagements


"Top Market Movers: Positive News Full Access: $ABVX 65.61$ XXXXXX% July XX 2025 Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 En"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1948046706513424601) 2025-07-23 15:45:02 UTC XXX followers, XXX engagements


"Upcoming catalysts to watch in April 2025 📅: $RAPT $PMN $CLNN $GNTA $BOLD $THTX $REGN $BMY $NBTX $AMPG $BCAK $EOSI $EVAX $TLX $OCGN $SNTI $KURA $PMT $OBT For detailed insights 📷"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1908846399388533049) 2025-04-06 11:37:00 UTC XXX followers, XXX engagements


"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1944785234513568049) 2025-07-14 15:45:06 UTC XXX followers, XXX engagements


"Top Market Movers: Positive News Full Access: $SRPT 22.29$ XXXXX% July XX 2025 Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides U"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1945872406637388248) 2025-07-17 15:45:08 UTC XXX followers, XXX engagements


"$GMED 53.30$ XXXX% July XX 2025 Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results"  
![@Biopharma_Watch Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1734221906151165952.png) [@Biopharma_Watch](/creator/x/Biopharma_Watch) on [X](/post/tweet/1947684361874378800) 2025-07-22 15:45:12 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about ticker, avg, $osrh, $thtx the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

X Week XXXXX -XX%
X Month XXXXXX +32%
X Months XXXXXX -XX%
X Year XXXXXXX +409%

Mentions: XX #

X Week XX -XX%
X Month XXX +30%
X Months XXX +937%
X Year XXX +1,410%

Followers: XXX #

X Week XXX +4.70%
X Month XXX +11%
X Months XXX +53%
X Year XXX +85%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% countries XXXX% exchanges XXXX%

Social topic influence ticker 2.94%, avg 1.96%, $osrh 1.96%, $thtx 1.96%, $7846t 0.98%, $adtx 0.98%, $cgtx 0.98%, mayo 0.98%, $bctx 0.98%, china XXXX%

Top assets mentioned Bruker, Corp. (BRKR) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Alkermes Inc. plc (ALKS) Magic Eden (ME) Regeneron Pharmaceuticals Inc (REGN) Bristol-Myers Squibb Co (BMY) Public Masterpiece Token (PMT) Oobit (OBT) Sarepta Therapeutics, Inc. (SRPT) GLOBUS MEDICAL INC (GMED)

Top Social Posts #

Top posts by engagements in the last XX hours

"$ADTX 1.31$ XXXX% July XX 2025 Aditxts Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic Ovarian Test"
@Biopharma_Watch on X 2025-07-24 15:45:08 UTC XXX followers, XX engagements

"Top Market Movers: Positive News Full Access: $CGTX 0.75$ XXXX% July XX 2025 Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesines Protection of Neurons and Synapses in Alzheimers Disease"
@Biopharma_Watch on X 2025-07-22 15:45:02 UTC XXX followers, XXX engagements

"$BCTX 0.83$ XXXX% July XX 2025 BriaCell Adds Mayo Clinic to Phase X Study in Metastatic Breast Cancer"
@Biopharma_Watch on X 2025-07-16 15:45:06 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $BIAF 0.32$ XXXX% July XX 2025 bioAffinity Technologies Announces Notification of China Patent Award for Companys Noninvasive Lung Cancer Diagnostic"
@Biopharma_Watch on X 2025-07-16 15:45:02 UTC XXX followers, XXX engagements

"Latest catalysts: $ANVS Catalyst Date - 2025-07-27 Drug - buntanetap Treatment - Alzheimer's disease"
@Biopharma_Watch on X 2025-07-25 15:45:03 UTC XXX followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $ANEB - 689.0K - 20.1M - XXXXX $CLSD - 8.3M - 227.9M - XXXXX $RNAZ - 164.0K - 4.2M - 25.42"
@Biopharma_Watch on X 2025-07-24 15:45:03 UTC XXX followers, XXX engagements

"$APYX 2.48$ XXXX% July XX 2025 Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August X 2025"
@Biopharma_Watch on X 2025-07-25 15:45:08 UTC XXX followers, XX engagements

"Sionna Therapeutics (NASDAQ: $SION) is making waves in a tough biotech IPO market. The company just raised $219M in its IPO targeting cystic fibrosis (CF) with a novel undruggable approach. Their therapies could restore near-normal CFTR function for over XX% of CF patients addressing gaps left by current treatments. Key points: Positive Phase X data for lead candidates SION-719 and SION-451 with Phase 2a trials starting soon Global CF therapy market projected to reach $39B by 2034 Strong cash runway through 2028 all analysts rate Sionna a Buy Major milestone: mid-2026 clinical data readout"
@Biopharma_Watch on X 2025-07-24 16:58:33 UTC XXX followers, XXX engagements

"$BRKR 35.80$ -XXXXX% July XX 2025 Bruker Announces Second Quarter 2025 Preliminary Results Plans to Hold Q2 Earnings Conference Call on August X 2025"
@Biopharma_Watch on X 2025-07-21 15:45:06 UTC XXX followers, XX engagements

"Top Market Movers: Positive News Full Access: $OSRH 1.01$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"
@Biopharma_Watch on X 2025-07-25 15:45:02 UTC XXX followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $XRTX - 148.1K - 3.5M - XXXXX $THTX - 477.5K - 10.6M - XXXXX $BCDA - 150.5K - 3.0M - 20.18"
@Biopharma_Watch on X 2025-07-04 15:45:03 UTC XXX followers, XX engagements

"$APLS Catalyst Date - 2025-07-28 Drug - EMPAVELI (pegcetacoplan) Treatment - C3 glomerulopathy primary immune complex membranoproliferative glomerulonephritis"
@Biopharma_Watch on X 2025-07-25 15:45:14 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $PSTV 0.62$ XXXXX% July XX 2025 Plus Therapeutics Announces $XXX Million Advance Payment from CPRIT"
@Biopharma_Watch on X 2025-07-24 15:45:02 UTC XXX followers, XXX engagements

"Latest catalysts: $IMAB Catalyst Date - 2025-07-02 Drug - Givastomig (Claudin XXXX x 4-1BB bispecific antibody) Treatment - Claudin 18.2-positive metastatic gastric cancers"
@Biopharma_Watch on X 2025-07-01 15:45:03 UTC XXX followers, XXX engagements

"Top Market Movers: Negative News Full Access: $EVO 3.66$ -XXXXX% July XX 2025 Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance"
@Biopharma_Watch on X 2025-07-21 15:45:03 UTC XXX followers, XXX engagements

"$ALKS 26.50$ -XXXX% July XX 2025 Alkermes Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1"
@Biopharma_Watch on X 2025-07-21 15:45:09 UTC XXX followers, XXX engagements

"$OSRH 1.08$ XXXX% July XX 2025 OSR Holdings Enters into Term Sheet to Acquire Woori IO a Pioneer in Noninvasive Glucose Monitoring Technology"
@Biopharma_Watch on X 2025-07-24 15:45:10 UTC XXX followers, XXX engagements

"$ATYR 6.71$ XXXXX% July XX 2025 aTyr Pharma Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis"
@Biopharma_Watch on X 2025-07-23 15:45:02 UTC XXX followers, XXX engagements

"Highest Volume Ticker - Price - Volume $PTPI - 0.07$ - 266.5M $OCEA - 0.02$ - 171.4M $NCNA - 0.05$ - 128.8M $ME - 0.61$ - 29.7M $CUTR - 0.10$ - 29.5M"
@Biopharma_Watch on X 2025-07-11 15:45:04 UTC XXX followers, XXX engagements

"$INMB Catalyst Date - 2025-07-27 Drug - XPro (selective soluble TNF inhibitor) Treatment - early Alzheimers Disease (AD) with biomarkers of inflammation"
@Biopharma_Watch on X 2025-07-21 15:45:11 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $ABVX 65.61$ XXXXXX% July XX 2025 Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 En"
@Biopharma_Watch on X 2025-07-23 15:45:02 UTC XXX followers, XXX engagements

"Upcoming catalysts to watch in April 2025 📅: $RAPT $PMN $CLNN $GNTA $BOLD $THTX $REGN $BMY $NBTX $AMPG $BCAK $EOSI $EVAX $TLX $OCGN $SNTI $KURA $PMT $OBT For detailed insights 📷"
@Biopharma_Watch on X 2025-04-06 11:37:00 UTC XXX followers, XXX engagements

"$REPL Catalyst Date - 2025-07-22 Drug - RP1 (vusolimogene oderparepvec) Treatment - advanced melanoma"
@Biopharma_Watch on X 2025-07-14 15:45:06 UTC XXX followers, XXX engagements

"Top Market Movers: Positive News Full Access: $SRPT 22.29$ XXXXX% July XX 2025 Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term Sustainable Growth and Provides U"
@Biopharma_Watch on X 2025-07-17 15:45:08 UTC XXX followers, XXX engagements

"$GMED 53.30$ XXXX% July XX 2025 Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results"
@Biopharma_Watch on X 2025-07-22 15:45:12 UTC XXX followers, XXX engagements